Select Equity Group’s LeMaitre Vascular LMAT Stock Holding History

Select Equity Group’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.4M	Buy	181,015 +80,545	+80%	+$8.26M	0.09%	118
2026 Q1	$11M	Buy	+100,470	New	+$9.58M	0.06%	138

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Select Equity Group's LMAT Position: Q2 2026 in Review

Select Equity Group increased its LeMaitre Vascular (LMAT) stake by 80% in Q2 2026, buying an estimated $8.26M and bringing the position to 181,015 shares worth $17.4M. The position accounts for 0.09% of the portfolio, ranked #118.

Select Equity Group first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Select Equity Group held 181,015 shares of LeMaitre Vascular worth $17.4M as of Q2 2026.
Select Equity Group bought 80,545 LeMaitre Vascular shares in Q2 2026, an estimated $8.26M.
LeMaitre Vascular made up 0.09% of Select Equity Group's portfolio in Q2 2026, its #118 holding.
Select Equity Group first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Select Equity Group's 13F filing for Q2 2026, filed 14 Aug 2026.